Clinical and MRI measures to identify non-acute MOG-antibody disease in adults

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults

Abstract MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease may overlap with those of other inflammatory demyelinating conditions posing diagnostic challenges, especially in non-acute phases and when serologic testing for MOG antibodies is unavailable or shows un...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Rosa Cortese, Marco Battaglini, Ferrán Prados, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Jens Wuerfel, Romain Marignier, Françoise Durand‐Dubief, Carolina de Medeiros Rimkus, Dagoberto Callegaro, Douglas Kazutoshi Sato, Massimo Filippi, Maria A. Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre‐Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriú, María Sepúlveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth Gulowsen Celius, Anne‐Katrin Proebstel, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Luca Carmisciano, Maria Pia Sormani, Frederik Barkhof, Nicola De Stefano, Olga Ciccarelli, C Enzinger, Ludwig Kappos, J Palace, Hugo Vrenken, Tarek Yousry
Natura:	Artigo
Lingua:	inglese
Pubblicazione:	2022
Accesso online:	https://doi.org/10.1093/brain/awac480
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The hippocampus in multiple sclerosis
di: Maria A. Rocca, et al.
Pubblicazione: (2018)

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
di: Massimo Filippi, et al.
Pubblicazione: (2016)

Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis
di: Olga Ciccarelli, et al.
Pubblicazione: (2024)

Unraveling treatment response in multiple sclerosis
di: Claudio Gasperini, et al.
Pubblicazione: (2018)

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge
di: Gasperini, Claudio, et al.
Pubblicazione: (2019)

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
di: Jaume Sastre‐Garriga, et al.
Pubblicazione: (2020)

Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis
di: Maria A. Rocca, et al.
Pubblicazione: (2021)

The ageing central nervous system in multiple sclerosis: the imaging perspective
di: Massimo Filippi, et al.
Pubblicazione: (2024)

Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis
di: Andrea Lazzarotto, et al.
Pubblicazione: (2024)

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
di: Sastre-Garriga, Jaume, et al.
Pubblicazione: (2020)

The current role of MRI in differentiating multiple sclerosis from its imaging mimics
di: Ruth Geraldes, et al.
Pubblicazione: (2018)

Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis
di: Cristina Granziera, et al.
Pubblicazione: (2021)

Longitudinal Assessment of Multiple Sclerosis with the Brain‐Age Paradigm
di: James H. Cole, et al.
Pubblicazione: (2020)

MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES
di: Filippi, M., et al.
Pubblicazione: (2016)

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis
di: Wottschel, Viktor, et al.
Pubblicazione: (2019)

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis
di: Viktor Wottschel, et al.
Pubblicazione: (2019)

Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging
di: Loredana Storelli, et al.
Pubblicazione: (2018)

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
di: Mike P. Wattjes, et al.
Pubblicazione: (2021)

Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting
di: Carmen Tur, et al.
Pubblicazione: (2018)

Quantification of Cervical Cord Cross-Sectional Area: Which Acquisition, Vertebra Level, and Analysis Software? A Multicenter Repeatability Study on a Traveling Healthy Volunteer
di: Lukas, Carsten, et al.
Pubblicazione: (2021)

Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody‐associated Disease, Aquaporin‐4 Antibody‐Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
di: Rosa Cortese, et al.
Pubblicazione: (2024)

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration
di: Hugh Kearney, et al.
Pubblicazione: (2013)

Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome
di: Massimo Filippi, et al.
Pubblicazione: (2021)

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
di: Nicola De Stefano, et al.
Pubblicazione: (2018)

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis
di: Alberto Calvi, et al.
Pubblicazione: (2022)

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
di: Amiri, Houshang, et al.
Pubblicazione: (2018)

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
di: Houshang Amiri, et al.
Pubblicazione: (2018)

Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis
di: Alessandro Cagol, et al.
Pubblicazione: (2023)

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease
di: Geraldes, Ruth, et al.
Pubblicazione: (2020)

MRI assessment of iron deposition in multiple sclerosis
di: Stefan Ropele, et al.
Pubblicazione: (2011)

Abnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI study
di: Rocca, Maria A., et al.
Pubblicazione: (2008)

Abnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI study
di: Maria A. Rocca, et al.
Pubblicazione: (2008)

MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis
di: Matthews, Lucy, et al.
Pubblicazione: (2015)

MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis
di: Lucy Matthews, et al.
Pubblicazione: (2014)

Mind the gap: from neurons to networks to outcomes in multiple sclerosis
di: Declan Chard, et al.
Pubblicazione: (2021)

Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study
di: JM Tillema, et al.
Pubblicazione: (2015)

Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis
di: Zhaleh Khaleeli, et al.
Pubblicazione: (2007)

Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study
di: Burggraaff, Jessica, et al.
Pubblicazione: (2020)

A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
di: Àlex Rovira, et al.
Pubblicazione: (2009)

Deep gray matter volume loss drives disability worsening in multiple sclerosis
di: Eshaghi, Arman, et al.
Pubblicazione: (2018)